• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随机对照试验的贡献者角色及新型CRediT-RCT提案。

The contributor roles for randomized controlled trials and the proposal for a novel CRediT-RCT.

作者信息

Zhang Zhongheng, Wang Stephen D, Li Grace S, Kong Guilan, Gu Hongqiu, Alfonso Fernando

机构信息

Department of Emergency Medicine, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.

AME Publishing Company, Hong Kong, China.

出版信息

Ann Transl Med. 2019 Dec;7(24):812. doi: 10.21037/atm.2019.12.96.

DOI:10.21037/atm.2019.12.96
PMID:32042828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6989869/
Abstract

BACKGROUND

The past decade has witnessed a rapid increase in the number of contributors per article, which has made explicitly defining the roles of each contributor even more challenging. The Contributor Roles Taxonomy (CRediT) was developed to explicitly define author roles, but there is a lack of empirical data on how CRediT is used in clinical trials. This study aimed to provide empirical data on the use of CRediT in randomized controlled trials (RCTs) and discuss some limitations of CRediT. A new taxonomy (CRediT-RCT) is proposed to explicitly define the author roles in RCTs.

METHODS

The electronic database of PubMed was searched from July 2017 to October 2019 to identify component trials with a randomized controlled design. Publications from the Public Library of Science (PLoS) were included because they embed the CRediT roles within the authors' metadata rather than solely as a separate paragraph of text.

RESULTS

A total of 446 articles involving 4,185 authors were included in the study. Most authors participated in the study's conceptualization (44.9%) and investigation (48.8%), but only a fraction of the authors participated in software management (7.4%). Many CRediT roles were correlated with each other: the strongest correlation was the one between funding acquisition and conceptualization (correlation metric =0.39), followed by the one between conceptualization and methodology (0.37). The authors who acquired funding (OR: 2.06; 95% CI: 1.54-2.76; P<0.001), did project administration (OR: 1.54; 95% CI: 1.17-2.03; P=0.002), performed supervision (OR: 2. 60; 95% CI: 1.93-3.52; P<0.001), wrote the original draft (OR: 4.83; 95% CI: 3.54-6.60; P<0.001), or were the first author (OR: 7.85; 95% CI: 5.71-10.87; P<0.001), were more likely to be the corresponding author. Also, while the original draft writing was significantly associated with the designation of the first author (OR: 37.49; 95% CI: 25.29-57.57; P<0.001), the first author did not perform review and editing (OR: 0.55; 95% CI: 0.40-0.75; P<0.001), supervision (OR: 0.49; 95% CI: 0.36-0.67; P<0.001), or resource management (OR: 0.71; 95% CI: 0.50-1.00; P=0.053). We further propose a novel Contributor Roles Taxonomy for Randomized Controlled Trials (CRediT-RCT) which includes 10 roles.

CONCLUSIONS

The present study provides empirical data on the use of CRediT for RCTs, and some limitations of the taxonomy are discussed. We further propose a new CRediT-RCT which includes 10 roles.

摘要

背景

在过去十年中,每篇文章的作者数量迅速增加,这使得明确界定每位作者的角色更具挑战性。贡献者角色分类法(CRediT)旨在明确界定作者角色,但缺乏关于CRediT在临床试验中如何使用的实证数据。本研究旨在提供关于CRediT在随机对照试验(RCT)中使用情况的实证数据,并讨论CRediT的一些局限性。我们提出了一种新的分类法(CRediT-RCT),以明确界定RCT中的作者角色。

方法

检索2017年7月至2019年10月期间PubMed的电子数据库,以识别采用随机对照设计的组成试验。纳入了来自科学公共图书馆(PLoS)的出版物,因为它们将CRediT角色嵌入作者的元数据中,而不是仅作为单独的一段文本。

结果

该研究共纳入446篇文章,涉及4185位作者。大多数作者参与了研究的概念化(44.9%)和调查(48.8%),但只有一小部分作者参与了软件管理(7.4%)。许多CRediT角色之间相互关联:最强的关联是资金获取与概念化之间的关联(相关系数=0.39),其次是概念化与方法学之间的关联(0.37)。获得资金的作者(比值比:2.06;95%置信区间:1.54-2.76;P<0.001)、进行项目管理的作者(比值比:1.54;95%置信区间:1.17-2.03;P=0.002)、进行监督的作者(比值比:2.60;95%置信区间:1.93-3.52;P<0.001)、撰写初稿的作者(比值比:4.83;95%置信区间:3.54-6.60;P<0.001)或第一作者(比值比:7.85;95%置信区间:5.71-10.87;P<0.001)更有可能成为通讯作者。此外,虽然撰写初稿与第一作者的指定显著相关(比值比:37.49;95%置信区间:25.29-57.57;P<0.001),但第一作者不进行审核和编辑(比值比:0.55;95%置信区间:0.40-0.75;P<0.001)、监督(比值比:0.49;95%置信区间:0.36-0.67;P<0.001)或资源管理(比值比:0.71;95%置信区间:0.50-1.00;P=0.053)。我们进一步提出了一种新的随机对照试验贡献者角色分类法(CRediT-RCT),其中包括10个角色。

结论

本研究提供了关于CRediT在RCT中使用情况的实证数据,并讨论了该分类法的一些局限性。我们进一步提出了一种新的CRediT-RCT,其中包括10个角色。

相似文献

1
The contributor roles for randomized controlled trials and the proposal for a novel CRediT-RCT.随机对照试验的贡献者角色及新型CRediT-RCT提案。
Ann Transl Med. 2019 Dec;7(24):812. doi: 10.21037/atm.2019.12.96.
2
'Author Contribution Details' and not 'Authorship Sequence' as a merit to determine credit: A need to relook at the current Indian practice.将“作者贡献详情”而不是“作者顺序”作为确定信用的标准:印度现行实践需要重新审视。
Natl Med J India. 2020 Jan-Feb;33(1):24-30. doi: 10.4103/0970-258X.308238.
3
Transparency in authors' contributions and responsibilities to promote integrity in scientific publication.透明度在作者的贡献和责任,以促进科学出版的诚信。
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2557-2560. doi: 10.1073/pnas.1715374115. Epub 2018 Feb 27.
4
Perceptions of authors' contributions are influenced by both byline order and designation of corresponding author.作者贡献的认知既受署名顺序的影响,也受通讯作者的指定影响。
J Clin Epidemiol. 2014 Sep;67(9):1049-54. doi: 10.1016/j.jclinepi.2014.04.006. Epub 2014 Jun 26.
5
CRediT for authors of articles published in the .作者贡献声明用于发表在. 的文章。
J Med Libr Assoc. 2021 Jul 1;109(3):362-364. doi: 10.5195/jmla.2021.1294.
6
Who writes dermatology randomized controlled trials? The need to specify the role of medical writers.谁撰写皮肤科随机对照试验?需要明确医学作家的作用。
Clin Exp Dermatol. 2021 Aug;46(6):1086-1088. doi: 10.1111/ced.14711. Epub 2021 Jun 4.
7
Contributions Made by Undergraduates to Research Projects: Using the CREDIT Taxonomy to Assess Undergraduate Research Experiences.本科生对研究项目的贡献:使用CREDIT分类法评估本科研究经历
Scholarsh Pract Undergrad Res. 2020 Fall;4(1):41-51. doi: 10.18833/spur/4/1/3.
8
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.预防性血小板输注用于预防血液系统疾病患者化疗和干细胞移植后的出血。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD004269. doi: 10.1002/14651858.CD004269.pub3.
9
Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.基于人群的生物医学性传播感染控制干预措施以减少艾滋病毒感染。
Cochrane Database Syst Rev. 2011 Mar 16(3):CD001220. doi: 10.1002/14651858.CD001220.pub3.
10
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

引用本文的文献

1
A systematic scoping review of the ethics of Contributor Role Ontologies and Taxonomies.贡献者角色本体论和分类学伦理的系统范围综述。
Account Res. 2024 Aug;31(6):678-705. doi: 10.1080/08989621.2022.2161049. Epub 2023 Jan 14.

本文引用的文献

1
Authorship Considerations for Publishing in Pharmacy Education Journals.出版于药学教育期刊的注意事项。
Am J Pharm Educ. 2019 Aug;83(6):7463. doi: 10.5688/ajpe7463.
2
Authorship: from credit to accountability. Reflections from the Editors' Network.作者署名:从荣誉到责任。编辑网络的思考。
Basic Res Cardiol. 2019 Apr 8;114(3):23. doi: 10.1007/s00395-019-0729-y.
3
Substantial contribution and accountability: best authorship practices for medical writers in biomedical publications.实质性贡献与责任:生物医学出版物中医学撰写人员的最佳署名规范
Curr Med Res Opin. 2018 Jun;34(6):1163-1168. doi: 10.1080/03007995.2018.1451832. Epub 2018 Apr 16.
4
Transparency in authors' contributions and responsibilities to promote integrity in scientific publication.透明度在作者的贡献和责任,以促进科学出版的诚信。
Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2557-2560. doi: 10.1073/pnas.1715374115. Epub 2018 Feb 27.
5
Site Principal Investigators in Multicenter Clinical Trials: Appropriately Recognizing Key Contributors.多中心临床试验中的现场主要研究者:恰当认可关键贡献者。
Circulation. 2017 Mar 28;135(13):1185-1187. doi: 10.1161/CIRCULATIONAHA.116.026650.
6
Endorsement of the Contributor Roles Taxonomy for the clarification of authorship.认可贡献者角色分类法以澄清作者身份。
J Periodontal Implant Sci. 2017 Feb;47(1):1. doi: 10.5051/jpis.2017.47.1.1. Epub 2017 Feb 28.
7
Addressing Authorship Issues Prospectively: A Heuristic Approach.前瞻性地解决作者身份问题:一种启发式方法。
Acad Med. 2017 Feb;92(2):143-146. doi: 10.1097/ACM.0000000000001285.
8
Univariate description and bivariate statistical inference: the first step delving into data.单变量描述和双变量统计推断:深入数据的第一步。
Ann Transl Med. 2016 Mar;4(5):91. doi: 10.21037/atm.2016.02.11.
9
Authorship in a multicenter clinical trial: The Heart Failure-A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Authorship and Publication (HAP) scoring system results.多中心临床试验中的作者身份:心力衰竭——运动训练结果对照试验(HF-ACTION)作者身份与发表(HAP)评分系统结果
Am Heart J. 2015 Apr;169(4):457-63.e6. doi: 10.1016/j.ahj.2014.11.022. Epub 2015 Jan 10.
10
Perceptions of authors' contributions are influenced by both byline order and designation of corresponding author.作者贡献的认知既受署名顺序的影响,也受通讯作者的指定影响。
J Clin Epidemiol. 2014 Sep;67(9):1049-54. doi: 10.1016/j.jclinepi.2014.04.006. Epub 2014 Jun 26.